Amicus Therapeutics, Inc. (FOLD) — DEF 14A Filings
All DEF 14A filings from Amicus Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Amicus Therapeutics Files 2025 Proxy Statement
— Apr 24, 2025 Risk: low
Amicus Therapeutics, Inc. filed its definitive proxy statement on April 24, 2025, for its annual meeting of stockholders scheduled for June 5, 2025. The filing, -
Amicus Therapeutics 2024 Annual Meeting Invitation
— Apr 24, 2024 Risk: low
Amicus Therapeutics, Inc. is holding its 2024 Annual Meeting of Stockholders on June 6, 2024, at 9:00 a.m. EDT, virtually via webcast. Stockholders will receive
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX